UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

High-dose Chemotherapy with Autologous Stem Cell Rescue in Stage IIIB Inflammatory Breast Cancer

Anticancer research, 2008-09, Vol.28 (5B), p.3139-3142

2008

Volltextzugriff (PDF)

Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or Glioblastoma multiforme (NSC 325319)

Investigational new drugs, 1999-05, Vol.17 (2), p.179-182

1999

Volltextzugriff (PDF)

Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies

American journal of clinical oncology, 2002-10, Vol.25 (5), p.528-534

2002

Volltextzugriff (PDF)

A phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube

Cancer research (Chicago, Ill.), 1991-04, Vol.51 (7), p.1803-1810

1991

Volltextzugriff (PDF)

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

Journal of clinical oncology, 1991-01, Vol.9 (1), p.175-188

1991

Volltextzugriff (PDF)

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia

Journal of clinical oncology, 1991-09, Vol.9 (9), p.1562-1569

1991

Volltextzugriff (PDF)

Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate

The American journal of medicine, 1990-09, Vol.89 (3), p.388-390

1990

Volltextzugriff (PDF)

Incidence and treatment of tumor lysis syndrome in patients with acute leukemia

Acta haematologica, 1994, Vol.91 (4), p.171

1994

Volltextzugriff (PDF)

Fludarabine phosphate in refractory hairy cell leukemia

American journal of hematology, 1991-05, Vol.37 (1), p.59-60

1991

Volltextzugriff (PDF)

Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia

Cancer, 1991-09, Vol.68 (6), p.1198-1200

1991

Volltextzugriff (PDF)

Cardiac complications observed in elderly patients following 2′‐deoxycoformycin therapy

American journal of hematology, 1991-11, Vol.38 (3), p.245-247

1991

Volltextzugriff (PDF)

Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent

Investigational new drugs, 1986-01, Vol.4 (3), p.279-284

1986

Volltextzugriff (PDF)

Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia

Leukemia, 1991-08, Vol.5 (8), p.712-714

1991

Volltextzugriff (PDF)

Chloroquinoxaline sulfonamide : a sulfanilamide antitumor agent entering clinical trials

Investigational new drugs, 1993-02, Vol.11 (1), p.1-9

1993

Volltextzugriff (PDF)

A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study

Journal of clinical oncology, 1991-08, Vol.9 (8), p.1487-1494

1991

Volltextzugriff (PDF)

Differentiating agents in the treatment of human malignancies

Cancer treatment reviews, 1986-09, Vol.13 (3), p.129-145

1986

Volltextzugriff (PDF)

Systemic chemotherapy of transitional cell carcinoma of the urothelium

Cancer treatment and research, 1989, Vol.42, p.151

1989

Volltextzugriff (PDF)

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule

Leukemia & lymphoma, 1991, Vol.6 (1), p.61-63

1991

Volltextzugriff (PDF)

Phase I Trial of Semustine Plus Weekly Fluorouracil and High-Dose Leucovorin Calcium in Patients With Advanced Colorectal Cancer

JNCI : Journal of the National Cancer Institute, 1989-12, Vol.81 (23), p.1840-1842

1989

Volltextzugriff (PDF)

Merbarone: an antitumor agent entering clinical trials

Investigational new drugs, 1987-01, Vol.5 (2), p.137-143

1987

Volltextzugriff (PDF)

Simultaneous measurement of the cell-differentiating agent hexamethylene bisacetamide and its metabolites by gas chromatography

Journal of chromatography, 1994-02, Vol.652 (2), p.149-159

1994

Volltextzugriff (PDF)

Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapy

International journal of clinical & laboratory research, 1992-06, Vol.21 (4), p.273-277

1992

Volltextzugriff (PDF)

Safety of Ligation of Aberrant Left Hepatic Artery Originating from Left Gastric Artery in Laparoscopic Gastrectomy for Gastric Cancer

Scientific reports, 2020-04, Vol.10 (1), p.5856-5856, Article 5856

2020

Volltextzugriff (PDF)

Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypes

European journal of human genetics : EJHG, 2011-05, Vol.19 (5), p.547-554

2011

Volltextzugriff (PDF)

Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypes

European journal of human genetics : EJHG, 2011-05, Vol.19 (5), p.547-554

2011

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(36)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Humans
(30)
Life Sciences & Biomedicine
(30)
Oncology
(20)
Biological And Medical Sciences
(19)
Male
(19)
Medical Sciences
(19)
Female
(16)
Middle Aged
(16)
Pharmacology. Drug Treatments
(16)
Antineoplastic Agents
(14)
Adult
(13)
Aged
(12)
Chemotherapy
(12)
Drug Evaluation
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Hematology
(6)
Antineoplastic Agents - Therapeutic Use
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)
Adolescent
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-dose Chemotherapy with Autologous Stem Cell Rescue in Stage IIIB Inflammatory Breast Cancer

Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or Glioblastoma multiforme (NSC 325319)

Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies

A phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia

Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate

Incidence and treatment of tumor lysis syndrome in patients with acute leukemia

Fludarabine phosphate in refractory hairy cell leukemia

Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia

Cardiac complications observed in elderly patients following 2′‐deoxycoformycin therapy

Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent

Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia

Chloroquinoxaline sulfonamide : a sulfanilamide antitumor agent entering clinical trials

A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study

Differentiating agents in the treatment of human malignancies

Systemic chemotherapy of transitional cell carcinoma of the urothelium

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule

Phase I Trial of Semustine Plus Weekly Fluorouracil and High-Dose Leucovorin Calcium in Patients With Advanced Colorectal Cancer

Merbarone: an antitumor agent entering clinical trials

Simultaneous measurement of the cell-differentiating agent hexamethylene bisacetamide and its metabolites by gas chromatography

Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapy

Safety of Ligation of Aberrant Left Hepatic Artery Originating from Left Gastric Artery in Laparoscopic Gastrectomy for Gastric Cancer

Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypes

Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypes

Suchergebnisse filtern